Skip to main content

Statutory instrument laid in the House of Commons and House of Lords, on Tuesday, 11 March 2025 by Karin Smyth on behalf of the Department of Health and Social Care.


Medicines (Products for Human Use) (Fees) (Amendment) Regulations


Secondary information

Type
Statutory instrument
Reference
SI 2025/317 
Session
2024-26
Coming into force
Tuesday, 1 April 2025
Procedure
Negative
40 days scrutiny period
Laying authority
Act
Related items
Contains explanatory memorandum
Yes
Contains impact assessment
Yes
Notes
Explanatory Memorandum withdrawn and replaced 21st March 2025
Subjects
Fees and charges Drugs Medicines and Healthcare products Regulatory Agency Regulation Blood transfusions Medical equipment
Legislation
Medicines and Medical Devices Act 2021
Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025
Library location
Commons Library: UP 805 2024-26; UC 66 2024-26
Link
View this Statutory instrument on www.legislation.gov.uk